Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?

Myles S Wolf*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)428-430
Number of pages3
JournalSeminars in Dialysis
Volume24
Issue number4
DOIs
StatePublished - Jul 1 2011

ASJC Scopus subject areas

  • Nephrology

Cite this